Consequences of the REDOXS and METAPLUS Trials

van Zanten ARH Hofman Z Heyland DK . Consequences of the REDOXS and METAPLUS trials: the end of an era of glutamine and antioxidant supplementation for critically ill patients? JPEN J Parenter Enteral Nutr. 2015;39(8):890-892.

van Zanten AR Sztark F Kaisers UX . High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA. 2014;312(5):514-524.

Buijs N van Leeuwen PA. Standard vs enriched high protein enteral nutrition in the ICU. JAMA. 2014;312(21):2288.

Heyland D Muscedere J Wischmeyer PE ; Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients [published correction appears in N Engl J Med. 2013;368(19):1853]. N Engl J Med. 2013;368(16):1489-1497.

Heyland DK Dhaliwal R Day AG ; Canadian Critical Care Trials Group. REducing Deaths due to OXidative Stress (The REDOXS Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc. 2006;65(3):250-263.

Heyland DK. Trial of glutamine and antioxidant supplementation in critically ill patients (REDOXS). In: ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; 2000-2014. http://clinicaltrials.gov/ct2/show/NCT00133978?term=REDOXS&rank=1. Accessed August 26, 2014.

Buijs N Vermeulen MA van Leeuwen PA. Glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;369(5):484.

Heyland DK Elke G Cook D ; on behalf of the Canadian Critical Care Trials Group. Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. 2015;39(4):401-409.

Fürst P Albers S Stehle . Dipeptides in clinical nutrition. Proc Nutr Soc. 1990;49:343-359.